Clinical Trials
3 trialsNCT06224673 2026-05-01
ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer
University of California, San Francisco
Phase 2 Not yet recruiting
NCT06663748 2024-10-29
ARX788 in HER2-positive Metastatic Breast Cancer Patients
Henan Cancer Hospital
Phase 2 Not yet recruiting
NCT06578286 2024-08-29
ARX788 in HER2-positive Metastatic Breast Cancer Patients Who Were Previously Treated With T-DXd
Fudan University
Phase 2 Not yet recruiting